Humacyte (NASDAQ:HUMA)

Human-based tissue scaffolds, including a biological vascular graft to provide vascular access to end-stage renal disease patients who need hemodialys....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Humacyte (NASDAQ:HUMA) plus 6037 other startups.

Learn More About Humacyte (NASDAQ:HUMA)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

Competing Startups

More